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Abstract. Determining both bilirubin’s concentration and its spatial distribution are important in disease diagnosis.
Here, for the first time, we applied quantitative multiwavelength photoacoustic microscopy (PAM) to detect
bilirubin concentration and distribution simultaneously. By measuring tissue-mimicking phantoms with different
bilirubin concentrations, we showed that the root-mean-square error of prediction has reached 0.52 and
0.83 mg∕dL for pure bilirubin and for blood-mixed bilirubin detection (with 100% oxygen saturation), respectively.
We further demonstrated the capability of the PAM system to image bilirubin distribution both with and without
blood. Finally, by underlaying bilirubin phantoms with mouse skins, we showed that bilirubin can be imaged with
consistent accuracy down to >400 μm in depth. Our results show that PAM has potential for noninvasive bilirubin
monitoring in vivo, as well as for further clinical applications. © 2012 Society of Photo-Optical Instrumentation Engineers (SPIE). [DOI:
10.1117/1.JBO.17.12.126019]
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1 Introduction
Bilirubin is a yellow-orange breakdown product of red blood
cells. Elevated bilirubin levels (>2.5 to 3.0 mg∕dL) in blood
streams and tissues are always associated with physiological
disorders, such as jaundice and hyperbilirubinemia.1,2 A high
bilirubin concentration may cause kernicterus, a kind of irrever-
sible brain damage in newborn babies.2,3 Thus, measuring the
bilirubin level plays an important role in the diagnosis of
jaundice and other diseases. Besides quantifying the average
bilirubin level, determination of its spatial distribution provides
additional information for such diagnoses. It has been suggested
that measuring both the serum and the transcutaneous bilirubin
levels concurrently will enable a more accurate identification of
jaundice.4,5 In addition, measuring the bilirubin distribution may
provide opportunities to study kernicterus (by analyzing the
movement of bilirubin across the blood-brain barrier and its
deposition into the brain tissue),5,6 to estimate the age of bruises
in forensic medicine,7 and to reveal the bilirubin photochemistry
interaction during phototherapy.8,9
Current techniques for bilirubin measurement have various
limitations. The conventional approach to measuring bilirubin
concentration involves extracting blood, which is invasive, and
only the total serum bilirubin level can be monitored, without
any spatial information. Noninvasive monitoring methods include
diffuse reflectance spectroscopy10–13 and hyperspectral ima-
ging.7,14 The former senses the overall concentration of bilirubin
in the skin without spatial resolution, whereas the latter maps
the relative bilirubin distributionwithout quantification. Therefore,
we still lack a technique for quantitative imaging of bilirubin.
Since it was first introduced in 2005, photoacoustic micro-
scopy (PAM) has been proven to be a promising modality for
both structural and functional imaging.15–20 In PAM, the object
is irradiated by a short-pulsed laser. Following the absorption of
light, a temperature rise generates an initial pressure rise, which
is propagated as a photoacoustic wave. This photoacoustic wave
is then detected by a focused ultrasonic transducer.21 Because
the initial pressure is proportional to the local energy absorbed,
photoacoustic measurements with multiple optical wavelengths
can provide spectral information of optical absorption. Based on
the different absorption spectra of oxyhemoglobin and deoxy-
hemoglobin, the oxygen saturation of hemoglobin (sO2) has
been successfully quantified by PAM with high accuracy and
spatial resolution.22,23 In addition, PAM has shown its feasibility
to detect other intrinsic contrasts in biological tissue, such as
DNA and RNA in nuclei,24 water,25 lipid,26 cytochrome c,27
and melanin.28,29
The motivation of this work is to image bilirubin distribution
quantitatively by using PAM. We first demonstrated that our
PAM system was capable of measuring the absorption spectra
of bilirubin and blood (including oxyhemoglobin and deoxyhe-
moglobin). Based on the absorption spectra, proper wavelengths
were chosen to measure pure bilirubin samples and mixed
bilirubin-blood samples. Then the root-mean-square error of
prediction (RMSEP) in both the pure and mixed samples was
measured. Last, the bilirubin distributions in tissue-mimicking
samples were imaged both without and with underlaid mouse
skins. We showed for the first time that bilirubin, both inside
and outside the blood vessels, can be imaged quantitatively
by PAM with relatively high accuracy.
2 Materials and Methods
2.1 Experimental System
A free-space transmission-mode PAM system was utilized for
bilirubin detection, as shown in Fig. 1.27 The laser pulse (5 ns
pulse width, 1 KHz pulse repetition rate), with a wavelength
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tunable from 210 to 2600 nm, was generated by an integrated
diode-pumped Q-switched laser and optical parametric oscillator
system (NT242-SH, Ekspla). The pulse was then filtered by a
2 mm iris (ID25SS, Thorlabs) to remove the nonuniform rim.
After being reflected by a mirror (PF10-03-G01, Thorlabs),
focused by a condenser lens (LA4380, Thorlabs), and filtered
by a 50 μmpinhole (P50C, Thorlabs), the light beamwas focused
by an optical objective with 0.3 numerical aperture (NA). The
excited photoacoustic waves were detected by a focused ultraso-
nic transducer (40 MHz central frequency, 80% bandwidth, and
0.5 NA). The ultrasonic transducer and optical objective were
aligned coaxially and confocally to achieve high sensitivity.
Each laser pulse yielded a one-dimensional depth-resolved
image (A-line) by recording the arrival timesof photoacoustic sig-
nals. A two-dimensional (2-D) scanning stage (PLS-85,MICOS)
held the sample and provided lateral scanning. We rendered our
result in the formof a 2-Dmaximumamplitude projection (MAP)
image, which was produced by projecting the maximum
amplitude of the three-dimensional (3-D) image along the
axial direction.
2.2 Phantom Preparation
In the experiments, bilirubin powder (B4126, Sigma-Aldrich)
was dissolved in dimethyl sulfoxide solution (Fisher Scientific)
and further diluted by water. To prepare the pure tissue-mimick-
ing sample, the bilirubin solution was mixed with 5% gelatin
(G1890, Sigma-Aldrich) and 1% intralipid (Fresenius Kabi).
The congealed sample had a thickness of 0.5 mm and an optical
scattering coefficient of approximately 100 cm−1. To prepare the
mixed sample (to mimic blood vessels), the bilirubin solution
was mixed with lysed bovine blood with a 75% sO2 (905–250,
Quad Five). Oxygenated hemoglobin was prepared by mixing
oxygen with lysed bovine blood (905–250, Quad Five) for
2 h. Deoxygenated hemoglobin was prepared by adding 33 mg
of sodium hydrosulfite (71699–50, Sigma-Aldrich) to 10 ml of
lysed bovine blood (905–250, Quad Five). The 75% sO2 blood
was prepared by mixing oxyhemoglobin and deoxyhemoglobin
at a ratio of 1∶3 and measured by an oximeter for validation.
To mimic a blood vessel, the mixture was then contained in
a microtube (made of platinum-cured silicone) with an inner
diameter of 300 μm and an outer diameter of 600 μm
(60985–700, VWR). To mimic the varied physiological levels
in real patients, phantoms were prepared with different concen-
trations of bilirubin.
2.3 Calibration Procedure
The PAM system was calibrated with pure samples with preset
bilirubin concentrations of 2, 4, 6, and 8 mg∕dL, and with a
preset blood concentration of 148 g∕L for quantification. The
sO2 was set to be ∼75%. The A-lines from each sample (pre-
pared as described previously) were averaged 10,000 times at
each optical wavelength. The peak PA signal amplitude versus
the wavelength was used to separately calculate the concentra-
tion by weighted least squares fit with the photoacoustic spectra
of bilirubin and blood. We repeated this calibration procedure
for the samples overlaid with mouse skins of different thick-
nesses (200, 400, and 600 μm) in order to compensate for
the depth-dependent light attenuation and obtain quantitative
results at these depths. It is also possible to estimate the light
attenuation by Beer’s law when depth-dependent calibration
is infeasible (such as in vivo and noninvasive applications).
2.4 Quantification of Bilirubin, Oxyhemoglobin, and
Deoxyhemoglobin Concentrations
Both the calibration and concentration measurements can be
described by the following equations:
φbiðλÞ ¼ kbi · εbiðλÞCbi (1)
φoxðλÞ ¼ kox · εoxðλÞCox (2)
φdeðλÞ ¼ kde · εdeðλÞCde; (3)
where φbiðλÞ, φoxðλÞ, and φdeðλÞ are the wavelength-dependent
photoacoustic signal amplitudes normalized with the laser pulse
energy (recorded in mV∕nJ) of bilirubin, oxyhemoglobin, and
deoxyhemoglobin, respectively; εbiðλÞ, εoxðλÞ, and εdeðλÞ are the
wavelength dependent molar absorption coefficients of biliru-
bin, oxyhemoglobin, and deoxyhemoglobin, respectively; Cbi,
Cox, and Cde are the concentrations of bilirubin, oxyhemoglo-
bin, and deoxyhemoglobin, respectively; and kbi, kox, and kde
are the calibration factors for bilirubin, oxyhemoglobin, and
deoxyhemoglobin, respectively. For calibration, Cbi, Cox, and
Cde were known, while kbi, kox, and kde were calculated by
weighted least squares fitting. kbi, kox, and kde were slightly dif-
ferent due to differences among the samples. For concentration
measurement, kbi, kox, and kde were from the calibration, while
Cbi, Cox, and Cde were calculated by weighted least squares
fitting. Here the variances of the photoacoustic signals are
used in the least squares fits as weighting terms.
For the mixture of bilirubin and blood, we can calculate all
bilirubin, oxyhemoglobin, and deoxyhemoglobin concentra-
tions by fitting the bilirubin and blood absorption spectra to
the photoacoustic signals:
φðλÞ ¼ kbi · εbiðλÞCbi þ kox · εoxðλÞCox þ kde · εdeðλÞCde;
(4)
where φðλÞ is the wavelength-dependent photoacoustic signal
amplitude.
Fig. 1 Schematic of the PAM system.
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To describe the measurement precision, the RMSEP of the
concentration can be defined as
RMSEPðCÞ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
e2s þ e2r
q
; (5)
where systematic error es and random error er are defined as
es ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃXn
i¼1
ðMi − CiÞ2∕n
s
(6)
and
er ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃXn
i¼1
δM2i ∕n
s
; (7)
respectively. Here, Ci,Mi, and δMi are the preset concentration,
mean measured concentration, and measurement standard
deviation of the i’th sample, respectively; and n is the total num-
ber of samples. RMSEP denotes the measurement error by com-
bining in quadrature both the systematic error and random error.
The systematic error describes the root-mean-squared difference
between the measurement and the actual value, mostly likely
originating from instrument calibration errors. The random
error describes the measurement fluctuation without averaging,
most likely originating from noise.
To quantitatively map the concentration distribution of bilir-
ubin in various samples, the samples were imaged at multiple
wavelengths, and each pixel of the co-registered multiwave-
length images was analyzed by the above method as described
by Eq. (4). To obtain the statistical ‘volume-averaged’ data, we
set a threshold of five times the noise level to separate the sample
and the background, and then averaged the signals within each
sample to get our final mean concentration value.
3 Results
3.1 Photoacoustic Spectra
We used PAM to measure the absorption spectra of bilirubin,
oxyhemoglobin, and deoxyhemoglobin by using pure bilirubin
(2 mg∕dL) and blood (37 g∕L) solutions, respectively. The rela-
tive optical absorption at each wavelength was calculated from
the average PA signal amplitude normalized by the laser pulse
energy. Figure 2(a) shows the absorption spectra of bilirubin,
oxyhemoglobin, and deoxyhemoglobin measured by the
PAM system, all fitting well to the absorption spectra measured
with a spectrophotometer (Cary 50 Bio UV/Visible, VARIAN).
The residual systematic difference between the bilirubin spectra
may have resulted from instrument errors. Because bilirubin has
a relatively high absorption in the wavelength range from 430 to
490 nm, we chose this range for the bilirubin measurement.
Likewise, because the absorption ratio between bilirubin and
blood is relatively high in the wavelength range from 460 to
490 nm [Fig. 2(b)],30–32 which enables an easier differentiation
of bilirubin from blood, we chose this range for the blood
absorption spectrum detection. Also, the wavelength range
from 540 to 545 nm was chosen, where blood has high absorp-
tion [Fig. 2(a)], but bilirubin has almost no absorption.31 We
used these component spectra measured by PAM as the standard
to decompose spectra of mixtures for the concentrations of bilir-
ubin, oxyhemoglobin, and deoxyhemoglobin.
3.2 Concentration Accuracy
We quantified the accuracy of bilirubin concentration
measurements by PAM in both pure and mixed samples. The
tissue-mimicking samples for the pure bilirubin measurements
were the same as those used in the calibration (bilirubin
concentrations of 2, 4, 6, and 8 mg∕dL; thickness of 200 μm).
The optical wavelength was varied from 430 to 460 nm. The
bilirubin concentration could be calculated simply from the
PA signal amplitudes after calibration, as shown in Fig. 3(a).
The RMSEP of the concentration was calculated by Eq. (5)
to be 0.52 mg∕dL for the pure bilirubin samples, where the
systematic error is 0.17 mg∕dL and the random error
is 0.49 mg∕dL.
For the mixed-sample measurement, we used four samples
with bilirubin-to-blood concentration ratios of 2, 4, 6, and
8 mg∕dL of bilirubin to 148 g∕L of blood. Two wavelength
ranges were chosen for this experiment. One was from 460
to 490 nm, where the molar extinction coefficient ratio between
bilirubin and blood is relatively high, as shown in Fig. 2(b).
The other was from 540 to 545 nm, where blood has high
absorption, but bilirubin has almost no absorption. The measure-
ments for the mixed samples with 75% and 100% sO2 are shown
in Fig. 3(b) and 3(c), respectively. According to Eq. (5), the
RMSEP value of the bilirubin for the 75% sO2 mixed samples
was calculated to be 1.04 mg∕dL, where the systematic error is
0.14 mg∕dL and the random error is 1.03 mg∕dL. For the 100%
sO2 mixed samples, the RMSEP value was 0.86 mg∕dL, where
the systematic error was 0.62 mg∕dL and the random error was
0.55 mg∕dL. Also, as shown in Fig. 3(b) and 3(c), the sO2 value
can be recovered in the mixture.
Fig. 2 Absorption spectra of bilirubin, oxyhemoglobin, and deoxyhe-
moglobin. (a) Relative absorption spectra of bilirubin, oxyhemoglobin,
and deoxyhemoglobin measured by PAM scaled by fitting to the
spectrophotometer measurement. (b) The molar extinction coefficient
ratio between bilirubin, oxyhemoglobin, and deoxyhemoglobin in
the wavelength range from 460 to 490 nm. μbili: relative absorption
coefficient of bilirubin. εbili: molar extinction coefficient of bilirubin.
μoxy: relative absorption coefficient of oxyhemoglobin. εoxy: molar
extinction coefficient of oxyhemoglobin. μdeoxy: relative absorption
coefficient of deoxyhemoglobin. εdeoxy: molar extinction coefficient
of deoxyhemoglobin. SP: spectrophotometer.
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3.3 Quantitative Bilirubin Mapping with and
without Blood
Next, we implemented quantitative PAM of pure bilirubin sam-
ples. Five congealed samples with different volume-averaged
bilirubin concentrations (1, 2, 3, 4, and 5 mg∕dL) were prepared
as described above, which covered the normal and elevated
bilirubin levels in humans. Each sample was cylindrical with
a diameter of about 0.5 mm (determined by the inner diameter
of the metal tube used as the sample mold), and the space
between the samples was filled with ultrasonic gel. With a step
size of 2 μm, a 3 mm by 0.3 mm area was scanned at 430 nm
wavelength, where bilirubin has a strong absorption, to acquire
PAM images of bilirubin distributions. The volume-averaged
concentrations of bilirubin in the samples were set to be 1 to
5 mg∕dL, from the top to the bottom of Fig. 4(a). The measured
average concentration of bilirubin in each sample was in accor-
dance with the preset concentration, as shown in Fig. 4(b). The
results show that the PAM system not only can measure the
bilirubin concentration but also can provide its spatial informa-
tion in the pure bilirubin sample.
We also detected the bilirubin spatial distribution in the
mixed samples with 75% sO2. Wavelengths of 460, 470, 480,
490, 540, and 545 nm were selected. Solutions with bilirubin-
to-blood ratios of 2, 4, 6, 8, and 10 mg∕dL to 148 g∕L were
prepared, corresponding to both normal and elevated ratios in
physiology. Five tubes with the same diameters as in the
previous experiment held the mixture samples. Here, a 4 mm
by 0.5 mm area was scanned with a step size of 2 μm. The
PAM images of the mixed solutions acquired at each wavelength
are shown in Fig. 5(a). Since blood has much higher absorption
than bilirubin, it is difficult to distinguish the bilirubin concen-
trations based merely on a single image. However, based on the
multiwavelength images, the image of the bilirubin concentra-
tion distribution can be calculated and is shown in Fig. 5(b). The
average bilirubin-to-blood ratios in the sample, from top to
bottom, ranged from 2 to 10 mg∕dL of bilirubin to 148 g∕L of
blood. The measured average concentrations of bilirubin are in
fair accordance with the preset concentrations, as shown in
Fig. 5(c).
Similarly, we detected the bilirubin spatial distribution in the
mixed samples with 100% sO2. The image of the bilirubin
concentration distribution is shown in Fig. 6(a). The measured
average concentrations of bilirubin are shown in Fig. 6(b). The
results in Figs. 5 and 6 illustrate that PAM can quantitatively
image bilirubin distributions in the presence of blood.
3.4 Bilirubin Imaging in Deep Tissue
Finally, to further demonstrate the ability of PAM to measure
bilirubin distribution in biological tissue, pure and mixed
samples underlaid by mouse skins (light illuminated from the
bottom) were imaged simultaneously. Fresh mouse skins, with
thicknesses of 200, 400, and 600 μm, were used to underlay the
samples. Pure bilirubin samples with concentrations of 2 and
4 mg∕dL and mixed samples with bilirubin-to-blood ratios of
4 and 8 mg∕dL to 148 g∕L (75% sO2) were prepared. In each
experiment, a 4 mm by 0.5 mm area was scanned, with a step
Fig. 3 The measured bilirubin concentration (C) of each sample versus
the preset concentration. (a) Pure bilirubin phantom. Bilirubin solution
mixed with (b) 75% sO2 blood and (c) 100% sO2 blood. Red circle:
experimental measurement of C. Blue solid line: ideal fit if the measured
and preset concentrations are identical. Black circle: experimental mea-
surement of sO2. Green dashed line: preset sO2. For the bilirubin blood
mixture sample with 75% sO2 and 100% sO2, the RMSEP of the con-
centration for bilirubin is calculated to be 1.04 mg∕dL and 0.83 mg∕dL,
respectively.
Fig. 4 Quantitative PAM of tissue-mimicking samples containing bilir-
ubin with varied concentrations. (a) Bilirubin distribution image. From
top to bottom in the image, the sample concentrations are 1, 2, 3, 4, and
5 mg∕dL, respectively. (b) Volume-averaged bilirubin concentrations
from the PAM measurements in each sample. Red circle: experimental
measurement. Blue line: ideal fit if the measured and preset concentra-
tions are identical.
Fig. 5 Multiwavelength PAM of the mixtures of bilirubin and blood
(75% sO2). (a) Quantitative PAM images at six optical wavelengths.
(b) Bilirubin distribution image calculated from the multiwavelength
PAM images. From top to bottom in the image, the bilirubin concen-
trations are 2, 4, 6, 8, and 10 mg∕dL, respectively, whereas the
blood concentration is 148 g∕L. (c) Volume-averaged bilirubin concen-
tration from the PAM measurements in each tube. Red circle: experi-
mental measurement. Blue line: ideal fit if the measured and preset
concentrations are identical.
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size of 2 μm (Fig. 7). In every image of Fig. 7, the upper two
samples are bilirubin solutions mixed with blood (with concen-
tration ratios of 8 and 4 mg∕dL to 148 g∕L), and the lower two
samples are pure bilirubin phantoms (with concentrations
of 4 and 2 mg∕dL). For pure and blood-mixed bilirubin, the
detection procedure was the same as discussed before. The
skin thicknesses in Fig. 7(a)–7(c) were 200, 400, and
600 μm, respectively. From Fig. 7, we can see that the measured
bilirubin concentrations were consistent with the preset values
when the skin thicknesses were 200 and 400 μm. However,
when the thickness of skin increased to 600 μm, the measure-
ments were less accurate. Table 1 shows bilirubin measurements
between phantoms without and with underlaid mouse skins.
With skin underlaid (200 and 400 μm), the measurement accu-
racy is similar to that without skin underlaid. However, when the
skin thickness increases to 600 μm, the results are less accurate
because of the low signal-to-noise ratio (SNR). Thus, at least a
400 μm penetration depth can be achieved by our method in
measuring bilirubin concentration both inside blood vessels
(i.e., the mixed samples) and outside blood vessels (i.e., the
pure samples).
4 Discussion
In these tissue phantom experiments, the quantitative measure-
ments down to 400 μm in depth rely on accurate calibration. The
influences of ultrasound refraction/reflection and depth depen-
dence of fluence may be very difficult to calibrate in future
in vivo experiments. However, since bilirubin is located shallow
in the skin (tens of micrometers, both in the dermis and epider-
mis), we should be able to map bilirubin distribution in vivowith
reasonable accuracy within tens of micrometers of depth, similar
to measuring oxygen saturation (sO2) in vivo.
19,22–23
There are four main types of absorbers in the visible spectral
range in the skin: oxyhemoglobin, deoxyhemoglobin, bilirubin,
and melanin.10 In blood vessels, absorption mainly originates
from oxyhemoglobin, deoxyhemoglobin, and bilirubin; while
outside the blood vessel absorption is mainly due to bilirubin
and melanin. As our work was focused on demonstrating the
feasibility of PAM measurements of bilirubin concentration
and distribution, the influence of melanin in the pure bilirubin
was not taken into account. However, in principle, if we choose
at least four optical wavelengths, each absorber’s concentration
can be quantified.21
As discussed above, tomeasure the pure bilirubin distribution,
only one wavelength is needed. For bilirubin mixed with blood,
with sufficient SNR, three wavelengths are enough to differenti-
ate the concentration of bilirubin from that of blood. But more
wavelengths (as used in our experiments) provide more data to
obtain a more accurate least squares fit because the SNR is
improved.However, usingmorewavelengths tomeasure the sam-
plewould take longer, which could be an important concern for in
vivo imaging. Thus, there is a trade-off between accuracy and
speed. To reduce the measurement time, voice-coil scanning33
or laser scanning34 can be utilized in the future.
A transmission-mode PAM system was used to detect
bilirubin distribution in this work. For clinical applications, it
is difficult to measure the skin by transmission-mode PAM
because of the large thickness of the tissue. Thus, it is preferred
Fig. 6 Multiwavelength PAM of the mixtures of bilirubin and blood
(100% sO2). (a) Bilirubin distribution image calculated from the
multiwavelength PAM images. From top to bottom in the image, the
bilirubin concentrations are 2, 4, 6, 8, and 10 mg∕dL, respectively,
whereas the blood concentration is 148 g∕L. (b) Volume-averaged
bilirubin concentration from the PAM measurements in each tube.
Red circle: experimental measurement. Blue line: ideal fit if the
measured and preset concentrations are identical.
Fig. 7 PAM of tissue phantoms with varied bilirubin concentrations.
The three images are acquired with underlaid mouse skins with
thickness of (a) 200 μm, (b) 400 μm, and (c) 600 μm, respectively. For
every image, the upper two tubes are bilirubin solutions mixed with
blood. The concentration ratios between bilirubin and blood are
8 mg∕dL: 148 g∕L and 4 mg∕dL: 148 g∕L, respectively. The lower
two samples are pure bilirubin phantoms with concentrations of 4
and 2 mg∕dL, respectively.
Table 1 Bilirubin concentrations measured by PAM in various phantoms without and with underlaid mouse skins.
Bilirubin C measured by PAM
Pure bilirubin phantoms Blood mixed solutions
2 mg∕dL 4 mg∕dL 4 mg∕dL 8 mg∕dL
No skin 2.40 0.68 3.88 1.14 4.03 0.76 8.21 1.50
200 μm 2.05 1.02 3.97 2.03 4.45 1.33 7.74 2.89
400 μm 2.23 1.23 3.73 1.77 4.0  1.13 7.72 2.16
600 μm 3.00 0.48 3.01 0.65 5.68 1.38 5.92 1.76
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to use reflection-mode PAM, which can be achieved by the use
of a parabolic mirror with a central hole for light delivery.35
When a healthy human with a very low bilirubin level in
blood is imaged, PAM currently may not be able to provide
accurate quantitative results. But PAM can complement other
techniques, such as blood analysis, by providing the spatial
distribution of bilirubin noninvasively. With further develop-
ment of our technique, we expect to detect relative levels of
albumin conjugated bilirubin, which is of clinical significance.36
Blood analyses can be used to measure the total serum bilirubin
level for a quantitative validation.
5 Conclusion
To the best of our knowledge, this is the first study to use PAM
for quantitative mapping of bilirubin distribution. The RMSEP
of concentration was quantified to be 0.52 mg∕dL for pure bilir-
ubin samples, 1.04 mg∕dL for bilirubin-blood mixtures with
75% sO2, and 0.83 mg∕dL for bilirubin-blood mixtures with
100% sO2, respectively. The bilirubin distribution, both in the
pure bilirubin samples and in the blood-mixed samples, was
imaged by multiwavelength PAM. Finally, imaging bilirubin
with underlaid mouse skins illustrated that at least a 400 μm
penetration depth can be achieved by PAM without noticeable
degradation in accuracy. Therefore, our method shows promise
to quantitatively image bilirubin in vivo for further clinical appli-
cations, such as the diagnosis of jaundice.
Acknowledgments
The authors gratefully acknowledge the suggestions made by
the reviewers of this manuscript, and by Prof. James Ballard
at Washington University in St. Louis. This work was sponsored
in part by National Institutes of Health grants R01 EB000712,
R01 EB008085, R01 CA134539, U54 CA136398, R01
CA157277, and R01 CA159959. L.W. has a financial interest
in Microphotoacoustics, Inc. and Endra, Inc., which, however,
did not support this work.
References
1. S. P. Roche and R. Kobos, “Jaundice in the adult patient,” Am. Fam.
Physician 69(2), 299–304 (2004).
2. Subcommittee on Hyperbilirubinemia (American Academy of Pedia-
trics), “Management of hyperbilirubinemia in the newborn infant 35
or more weeks of gestation,” Pediatrics 114(1), 297–316 (2004).
3. V. K. Bhutani and L. Johnson, “Kernicterus in the 21st century:
frequently asked questions,” J. Perinatol. 29(Suppl. 1), S20–S24
(2009).
4. C. E. Ahlfors, “Criteria for exchange transfusion in jaundiced
newborns,” Pediatrics 93(3), 488–494 (1994).
5. S. N. EI-Beshbishi et al., “Hyperbilirubinemia and transcutaneous
bilirubinometry,” Clin. Chem. 55(7), 1280–1287 (2009).
6. F. F. Rubaltelli et al., “Transcutaneous bilirubin measurement: a multi-
center evaluation of a new device,” Pediatrics 107(6), 1264–1271
(2001).
7. L. L. Randeberg, E. Larsen, and L. Svaasand, “Characterization of vas-
cular structures and skin bruises using hyperspectral imaging, image
analysis and diffusion theory,” J. Biophoton. 3(1–2), 53–65 (2010).
8. Y. Yamauchi and I. Yamanouchi, “Transcutaneous bilirubinometry:
bilirubin kinetics of the skin and serum during and after phototherapy,”
Biol. Neonate. 56(5), 263–269 (1989).
9. G. Agati et al., “Quantum yield and skin filtering effects on the forma-
tion rate of lumirubin,” J. Photochem. Photobiol. B 18(2–3), 197–203
(1993).
10. S. L. Jacques et al., “Developing an optical fiber reflectance
spectrometer to monitor bilirubinemia in neonates,” Proc. SPIE 2975,
115–124 (1997).
11. S. K. Alla et al., “Point-of-care device for quantification of bilirubin in
skin tissue,” IEEE Trans. Biomed. Eng. 58(3), 777–780 (2011).
12. M. J. Maisels et al., “Evaluation of a new transcutaneous bilirubin-
ometer,” Pediatrics 113(6), 1628–1635 (2004).
13. G. Bertini et al., “Transcutaneous bilirubin measurement: evaluation of
Bilitest,” Neonatology 93(2), 101–105 (2008).
14. G. Payne et al., “Applying visible hyperspectral (chemical) imaging to
estimate the age of bruises,” Med. Sci. Law 47(3), 225–232 (2007).
15. K. Maslov, G. Stoica, and L. V. Wang, “In vivo dark-field reflection-
mode photoacoustic microscopy,” Opt. Lett. 30(6), 625–627 (2005).
16. H. F. Zhang et al., “Functional photoacoustic microscopy for high-
resolution and noninvasive in vivo imaging,” Nat. Biotechnol. 24(7),
848–851 (2006).
17. K. Maslov et al., “Optical-resolution photoacoustic microscopy for in
vivo imaging of single capillaries,” Opt. Lett. 33(9), 929–931 (2008).
18. L. V. Wang, “Multiscale photoacoustic microscopy and computed
tomography,” Nat. Photon. 3(9), 503–509 (2009).
19. S. Hu and L. V. Wang, “Photoacoustic imaging and characterization of
the microvasculature,” J. Biomed. Opt. 15(1), 011101 (2010).
20. L. V. Wang and S. Hu, “Photoacoustic tomography: in vivo imaging
from organelles to organs,” Science 335(6075), 1458–1462 (2012).
21. L. V. Wang and H. Wu, Biomedical Optics: Principles and Imaging,
Wiley, Hoboken, NJ (2007).
22. J. Yao et al., “Label-free oxygen-metabolic photoacoustic microscopy
in vivo,” J. Biomed. Opt. 16(7), 076003 (2011).
23. E. W. Stein, K. Maslov, and L. V. Wang, “Noninvasive, in vivo imaging
of blood-oxygenation dynamics within the mouse brain using photoa-
coustic microscopy,” J. Biomed. Opt. 14(2), 020502 (2009).
24. D. K. Yao et al., “In vivo label-free photoacoustic microscopy of cell
nuclei by excitation of DNA and RNA,” Opt. Lett. 35(24), 4139–4141
(2010).
25. Z. Xu, C. H. Li, and L. V. Wang, “Photoacoustic tomography of water in
phantoms and tissue,” J. Biomed. Opt. 15(3), 036019 (2010).
26. H. W. Wang et al., “Label-free bond-selective imaging by listening to
vibrationally excited molecules,” Phy. Rev. Lett. 106(23), 238106
(2011).
27. C. Zhang et al., “Label-free photoacoustic microscopy of cytochrome c
in cells,” Proc. SPIE 8223, 82231W (2012).
28. Y. Wang et al., “Fiber-laser-based photoacoustic microscopy and
melanoma cell detection,” J. Biomed. Opt. 16(1), 011014 (2011).
29. C. Zhang, K. Maslov, and L. V. Wang, “Subwavelength-resolution
label-free photoacoustic microscopy of optical absorption in vivo,”
Opt. Lett. 35(19), 3195–3197 (2010).
30. J. M. Schmitt, “Optical measurement of blood oxygen by implantable
telemetry,” PhD Dissertation, Stanford University (1986).
31. G. Agati and F. Fusi, “New trends in photobiology recent advances in
bilirubin photophysics,” J. Photochem. Photobiol. 7(1), 1–14 (1990).
32. J. M. Dixon, M. Taniguchi, and J. S. Lindsey, “PhotochemCAD 2. A
refined program with accompanying spectral databases for photochemi-
cal calculations,” Photochem. Photobiol. 81(1), 212–213 (2005).
33. L. Wang et al., “Fast voice-coil scanning optical-resolution photoacous-
tic microscopy,” Opt. Lett. 36(2), 139–141 (2011).
34. B. Rao et al., “Real-time four-dimensional optical-resolution photoa-
coustic microscopy with Au nanoparticle-assisted subdiffraction-limit
resolution,” Opt. Lett. 36(7), 1137–1139 (2011).
35. C. Zhang et al., “Reflection-mode submicron-resolution in vivo
photoacoustic microscopy,” J. Biomed. Opt. 17(2), 020501 (2012).
36. C. Mullon and R. Langer, “Determination of conjugated and total
bilirubin in serum of neonates, with use of bilirubin oxidase,” Clin.
Chem. 33(10), 1822–1825 (1987).
Journal of Biomedical Optics 126019-6 December 2012 • Vol. 17(12)
Zhou et al.: Photoacoustic microscopy of bilirubin in tissue phantoms
Downloaded From: http://biomedicaloptics.spiedigitallibrary.org/ on 06/29/2016 Terms of Use: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
